<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03059875</url>
  </required_header>
  <id_info>
    <org_study_id>GYNECO ONCOGER</org_study_id>
    <nct_id>NCT03059875</nct_id>
  </id_info>
  <brief_title>Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter)</brief_title>
  <official_title>Place of Comprehensive Geriatric Assessment (CGA) in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter): Comparison Between CGA Before Surgery (Strategy A) vs. After Surgery (Strategy B)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <brief_summary>
    <textblock>
      The risk of diagnosis of cancer increases with age, especially breast cancer in elderly&#xD;
      women. Elderly population is heterogeneous, regarding physiological reserves, comorbidities,&#xD;
      disability and geriatric conditions. Comprehensive geriatric assessment (CGA) is a&#xD;
      multidimensional approach to determine geriatric profile, in helping the therapeutic&#xD;
      strategy. In-patients with diagnosis of cancer are screened with the FOG (oncology geriatric&#xD;
      filter), to identify vulnerable subjects who may benefit from CGA. This scale of ten&#xD;
      questions includes geriatric domains such as functional status, nutrition, mood, cognitive&#xD;
      abilities and comorbidities. In elderly patients with breast cancer considered as fit&#xD;
      (FOG=0), CGA is not necessary before adjuvant treatment. In vulnerable patients (FOG ≤ 1 and&#xD;
      &lt; 3), CGA is held in routine to discuss the adjuvant therapy feasibility. Patients with FOG ≥&#xD;
      4 underwent CGA if palliative care is considered.&#xD;
&#xD;
      Patients in the intermediate group (FOG 1-3) are randomized to determine time of CGA, before&#xD;
      or after surgery.&#xD;
&#xD;
      The aims of this study are to assess the outcomes regarding the time of CGA, in elderly&#xD;
      female patients with breast cancer management, and to define the optimal place of CGA in care&#xD;
      pathway.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 30, 2014</start_date>
  <completion_date type="Anticipated">July 31, 2025</completion_date>
  <primary_completion_date type="Actual">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare Comprehensive Geriatric Assessment before the surgery and Comprehensive Geriatric Assessment after the surgery</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life of patients</measure>
    <time_frame>5 years</time_frame>
    <description>Questionnary EORTC QLQ - BR33</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with their management</measure>
    <time_frame>5 years</time_frame>
    <description>Questionnary REPERES 60 - Consumer Satisfaction Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare proportions of patients who received adjuvant chemotherapy and / or radiation standard</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare time to take care of Comprehensive Geriatric Assessment before the surgery and Comprehensive Geriatric Assessment after the surgery</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the proportions of patients receiving adjuvant therapy, including complete hormone therapy</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Surgery</condition>
  <condition>75 Years Old and More</condition>
  <condition>Female Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Strategy A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Comprehensive Geriatric Assessment before the surgery of breast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strategy B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Comprehensive Geriatric Assessment after the surgery of breast</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Medical consultation for a Standardized Geriatric Evaluation</intervention_name>
    <arm_group_label>Strategy A</arm_group_label>
    <arm_group_label>Strategy B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First breast cancer localized, indication of surgery&#xD;
&#xD;
          -  Onco-geriatric filter (FOG) &gt;= 1 ou &lt; 4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male, less of 75 years old&#xD;
&#xD;
          -  Contraindication of surgery&#xD;
&#xD;
          -  Breast cancer with metastasis&#xD;
&#xD;
          -  Onco-geriatric filter (FOG) = 0 or 4&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Center</name>
      <address>
        <city>Angouleme</city>
        <zip>16959</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital center</name>
      <address>
        <city>Bressuire</city>
        <zip>79302</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Center</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital center</name>
      <address>
        <city>Niort</city>
        <zip>79021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Center</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital center</name>
      <address>
        <city>Saintes</city>
        <zip>17108</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 9, 2017</study_first_submitted>
  <study_first_submitted_qc>February 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breastcancer</keyword>
  <keyword>Standardized Geriatric Evaluation</keyword>
  <keyword>Onco-Geriatric Filter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

